These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15612337)

  • 1. Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?
    Crown WH; Berndt ER; Baser O; Finkelstein SN; Witt WP; Maguire J; Haver KE
    Front Health Policy Res; 2004; 7():95-127. PubMed ID: 15612337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.
    Campbell JD; Allen-Ramey F; Sajjan SG; Maiese EM; Sullivan SD
    Am J Manag Care; 2011 Oct; 17(10):703-10. PubMed ID: 22106463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of antidepressant prescribing concentration to treatment duration and cost.
    Hodgkin D; Merrick EL; Hiatt D
    J Ment Health Policy Econ; 2012 Mar; 15(1):3-11. PubMed ID: 22611088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
    Cecil WT; Barnes J; Shea T; Coulter SL
    J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratio of controller to total asthma medications: determinants of the measure.
    Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M
    Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia.
    Doshi JA; Li P; Desai S; Marcus SC
    J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dutch GPs' perceptions: the influence of out-of-pocket costs on prescribing.
    Kasje WN; Timmer JW; Boendermaker PM; Haaijer-Ruskamp FM
    Soc Sci Med; 2002 Nov; 55(9):1571-8. PubMed ID: 12297243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries.
    Gilman BH; Kautter J
    Health Serv Res; 2008 Apr; 43(2):478-95. PubMed ID: 18370964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive therapy for asthmatic children under Florida Medicaid: changes during the 1990s.
    David C
    J Asthma; 2004 Sep; 41(6):655-61. PubMed ID: 15584315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice setting.
    Fortess EE; Soumerai SB; McLaughlin TJ; Ross-Degnan D
    J Am Geriatr Soc; 2001 Jun; 49(6):793-7. PubMed ID: 11454120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician communication regarding cost when prescribing asthma medication to children.
    Patel MR; Coffman JM; Tseng CW; Clark NM; Cabana MD
    Clin Pediatr (Phila); 2009 Jun; 48(5):493-8. PubMed ID: 19164133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a three-tier formulary on antidepressant utilization and expenditures.
    Hodgkin D; Parks Thomas C; Simoni-Wastila L; Ritter GA; Lee S
    J Ment Health Policy Econ; 2008 Jun; 11(2):67-77. PubMed ID: 18509214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicians' opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern states.
    Khan S; Sylvester R; Scott D; Pitts B
    J Manag Care Pharm; 2008 Oct; 14(8):780-9. PubMed ID: 18983207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of an increase in prescription copayment on utilization of low-sedating antihistamines and nasal steroids.
    Meissner BL; Moore WM; Shinogle JA; Reeder CE; Little JM
    J Manag Care Pharm; 2004; 10(3):226-33. PubMed ID: 15228372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy.
    Goldman DP; Joyce GF; Karaca-Mandic P
    Am J Manag Care; 2006 Jan; 12(1):21-8. PubMed ID: 16402885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Income-based drug benefit policy: impact on receipt of inhaled corticosteroid prescriptions by Manitoba children with asthma.
    Kozyrskyj AL; Mustard CA; Cheang MS; Simons FE
    CMAJ; 2001 Oct; 165(7):897-902. PubMed ID: 11599328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of asthma prescription measures and health system performance based on emergency department utilization.
    Fuhlbrigge A; Carey VJ; Adams RJ; Finkelstein JA; Lozano P; Weiss ST; Weiss KB
    Med Care; 2004 May; 42(5):465-71. PubMed ID: 15083107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.
    Dusetzina SB; Huskamp HA; Winn AN; Basch E; Keating NL
    JAMA Oncol; 2018 Jun; 4(6):e173598. PubMed ID: 29121177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF; Escarce JJ; Solomon MD; Goldman DP
    JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.